Hilsenbeck SG - Search Results

1

AP-1 blockade inhibits the growth of normal and malignant breast cells.

Ludes-Meyers JH, Liu Y, Muñoz-Medellin D, Hilsenbeck SG, Brown PH. Ludes-Meyers JH, et al. Among authors: hilsenbeck sg. Oncogene. 2001 May 17;20(22):2771-80. doi: 10.1038/sj.onc.1204377. Oncogene. 2001. PMID: 11420689

2

Recombinant insulin-like growth factor binding protein-1 inhibits IGF-I, serum, and estrogen-dependent growth of MCF-7 human breast cancer cells.

Figueroa JA, Sharma J, Jackson JG, McDermott MJ, Hilsenbeck SG, Yee D. Figueroa JA, et al. Among authors: hilsenbeck sg. J Cell Physiol. 1993 Nov;157(2):229-36. doi: 10.1002/jcp.1041570204. J Cell Physiol. 1993. PMID: 7693722

3

Inhibition of estrogen-induced breast cancer cell proliferation by reduction in autocrine transforming growth factor alpha expression.

Reddy KB, Yee D, Hilsenbeck SG, Coffey RJ, Osborne CK. Reddy KB, et al. Among authors: hilsenbeck sg. Cell Growth Differ. 1994 Dec;5(12):1275-82. Cell Growth Differ. 1994. PMID: 7696176

4

The small heat shock protein hsp27 is correlated with growth and drug resistance in human breast cancer cell lines.

Oesterreich S, Weng CN, Qiu M, Hilsenbeck SG, Osborne CK, Fuqua SA. Oesterreich S, et al. Among authors: hilsenbeck sg. Cancer Res. 1993 Oct 1;53(19):4443-8. Cancer Res. 1993. PMID: 8402609

5

Polyethylene glycol conjugated insulin-like growth factor binding protein-1 (IGFBP-1) inhibits growth of breast cancer in athymic mice.

Van den Berg CL, Cox GN, Stroh CA, Hilsenbeck SG, Weng CN, McDermott MJ, Pratt D, Osborne CK, Coronado-Heinsohn EB, Yee D. Van den Berg CL, et al. Among authors: hilsenbeck sg. Eur J Cancer. 1997 Jun;33(7):1108-13. doi: 10.1016/s0959-8049(97)00071-3. Eur J Cancer. 1997. PMID: 9376191

6

IGF system components as prognostic markers in breast cancer.

Lee AV, Hilsenbeck SG, Yee D. Lee AV, et al. Among authors: hilsenbeck sg. Breast Cancer Res Treat. 1998 Feb;47(3):295-302. doi: 10.1023/a:1005915420341. Breast Cancer Res Treat. 1998. PMID: 9516083 Review.

7

p53 mutation and tamoxifen resistance in breast cancer.

Elledge RM, Lock-Lim S, Allred DC, Hilsenbeck SG, Cordner L. Elledge RM, et al. Among authors: hilsenbeck sg. Clin Cancer Res. 1995 Oct;1(10):1203-8. Clin Cancer Res. 1995. PMID: 9815913

8

Hsp27 overexpression inhibits doxorubicin-induced apoptosis in human breast cancer cells.

Hansen RK, Parra I, Lemieux P, Oesterreich S, Hilsenbeck SG, Fuqua SA. Hansen RK, et al. Among authors: hilsenbeck sg. Breast Cancer Res Treat. 1999 Jul;56(2):187-96. doi: 10.1023/a:1006207009260. Breast Cancer Res Treat. 1999. PMID: 10573111

9

9-cis-Retinoic acid suppresses mammary tumorigenesis in C3(1)-simian virus 40 T antigen-transgenic mice.

Wu K, Kim HT, Rodriquez JL, Munoz-Medellin D, Mohsin SK, Hilsenbeck SG, Lamph WW, Gottardis MM, Shirley MA, Kuhn JG, Green JE, Brown PH. Wu K, et al. Among authors: hilsenbeck sg. Clin Cancer Res. 2000 Sep;6(9):3696-704. Clin Cancer Res. 2000. PMID: 10999763

10

Oxidative stress and AP-1 activity in tamoxifen-resistant breast tumors in vivo.

Schiff R, Reddy P, Ahotupa M, Coronado-Heinsohn E, Grim M, Hilsenbeck SG, Lawrence R, Deneke S, Herrera R, Chamness GC, Fuqua SA, Brown PH, Osborne CK. Schiff R, et al. Among authors: hilsenbeck sg. J Natl Cancer Inst. 2000 Dec 6;92(23):1926-34. doi: 10.1093/jnci/92.23.1926. J Natl Cancer Inst. 2000. PMID: 11106684

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

369 results

Search Page

Filters